Form 4: BioLife Solutions Director Timothy Moore Reports Acquisition of Common Stock

Director Timothy L. Moore reports acquiring 11,264 shares of BioLife Solutions common stock on March 8, 2024.

Summary

• On March 8, 2024, Timothy L. Moore, a director of BioLife Solutions Inc., acquired 11,264 shares of common stock.
• The acquisition was made under the BioLife Solutions 2023 Performance Incentive Plan.
• Following the transaction, Moore directly owns 29,897 shares of BioLife Solutions common stock.
• The restricted stock vests fully on the first anniversary of the grant date.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard regulatory filing reporting an insider transaction. The director's purchase could be seen as slightly positive, but the document itself is simply a factual report.

Positives

• A director's acquisition of company stock can be seen as a positive signal, indicating confidence in the company's future performance.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC when a company insider, such as a director, buys or sells shares of the company's stock. It provides transparency to the market regarding insider transactions.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment, as it signals confidence from a company director.

Key Dates